Comment on the “Use of intravenous immunoglobulin for the treatment of severe COVID-19”
Main Article Content
Abstract
-
Article Details
Issue
Section
Correspondence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication.
How to Cite
Comment on the “Use of intravenous immunoglobulin for the treatment of severe COVID-19”. (2025). Southern African Journal of Critical Care, 41(3), e3107. https://doi.org/10.7196/SAJCC.2025.v41i3.3107
References
1. Mensky G, van Blydenstein A, Damelin J, Omar S. Use of intravenous immunoglobulin for the treatment of severe COVID‐19 in the Chris Hani Baragwanath Academic Hospital intensive care unit, Johannesburg, South Africa. South Afr J Crit Care 2024;40(3):e1897. https://doi.org/10.7196/ SAJCC.2024.v40i3.1897